AR and VR in Healthcare Comprehensive Study by Type (Augmented Reality, -Surgical Application, -Rehabilitation, -Training & Continuing Medical Education, Virtual Reality, -Simulation, -Diagnostics, -Virtual Reality Exposure Therapy (VRET), -Rehabilitation, -Pain Distraction), Application (Hospitals, Clinics, and Surgical Centers, Research Organizations and Pharma Companies, Research and Diagnostics Laboratories, Government and Defense Institutions, Others) Players and Region - Global Market Outlook to 2032

AR and VR in Healthcare Market by XX Submarkets | Forecast Years 2025-2032 | CAGR: 36.89%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global AR and VR in Healthcare Market Overview:
Technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditure, growing usage in surgical procedures, and medical training are some of the fundamental factors anticipated to boost the growth and adoption of augmented reality (AR) and virtual reality (VR) technologies in the healthcare industry. Augmented reality (AR) currently holds a major share in healthcare applications like surgery and medical education, while virtual reality (VR) is growing faster, especially in simulation and rehabilitation. As per latest study released by AMA Research, the Global AR and VR in Healthcare market is expected to see growth rate of 36.89%

AttributesDetails
Study Period2020-2032
Base Year2024
Forecast Period2024-2032
Historical Period2020-2024
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increased Investment in the Healthcare AR and VR

Market Growth Drivers:
Increasing Penetration of Connected Devices in the Healthcare Sector and Growing Need to Reduce the Healthcare Costs

Challenges:
Overcoming Social Challenges, Concerns Regarding Data Privacy and Lack of Compatibility and Interoperability Between AR and VR Solutions Offered By Different Vendors

Restraints:
Lack of Competence in Deployment of the AR and VR Solutions and Lack of Expertise Among Medical Practitioners to Adopt New Technologies

Opportunities:
Increasing Demand for AR and VR in Emerging Markets and Increased Use of Augmented Reality and Virtual Reality in Fitness Management

Competitive Landscape:

Some of the key players profiled in the report are Google (US), Microsoft (US), DAQRI (US), Psious (Spain), Mindmaze (Switzerland), Firsthand Technology (US), Medical Realities (UK), Atheer (US), Augmedix (US), Oculus VR (US), CAE Healthcare (US), Philips Healthcare (Netherlands & US), 3D Systems (US), VirtaMed (Switzerland), HTC (Taiwan), Siemens Healthineers (Germany) and Virtually Better (US)..

Latest Market Insights:
In December 2023, EON Reality announced the renewal of its strategic partnership with the Children’s Hospital of Orange County (CHOC). This partnership highlights a mutual dedication to leveraging advanced AR and VR technologies to revolutionize pediatric healthcare education and improve patient experiences.

In March 2024, Siemens Healthineers launched an app developed for Apple Vision Pro to enable medical students, surgeons, and patients to view interactive, immersive holograms of the human body in medical scans in real-world settings. It can assist in medical education, surgical planning, or visualizing procedures.

What Can be Explored with the AR and VR in Healthcare Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global AR and VR in Healthcare Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in AR and VR in Healthcare
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global AR and VR in Healthcare market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in AR and VR in Healthcare market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Augmented Reality
  • -Surgical Application
  • -Rehabilitation
  • -Training & Continuing Medical Education
  • Virtual Reality
  • -Simulation
  • -Diagnostics
  • -Virtual Reality Exposure Therapy (VRET)
  • -Rehabilitation
  • -Pain Distraction
By Application
  • Hospitals, Clinics, and Surgical Centers
  • Research Organizations and Pharma Companies
  • Research and Diagnostics Laboratories
  • Government and Defense Institutions
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Penetration of Connected Devices in the Healthcare Sector
      • 3.2.2. Growing Need to Reduce the Healthcare Costs
    • 3.3. Market Challenges
      • 3.3.1. Overcoming Social Challenges
      • 3.3.2. Concerns Regarding Data Privacy
      • 3.3.3. Lack of Compatibility and Interoperability Between AR and VR Solutions Offered By Different Vendors
    • 3.4. Market Trends
      • 3.4.1. Increased Investment in the Healthcare AR and VR
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global AR and VR in Healthcare, by Type, Application and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global AR and VR in Healthcare (Value)
      • 5.2.1. Global AR and VR in Healthcare by: Type (Value)
        • 5.2.1.1. Augmented Reality
        • 5.2.1.2. -Surgical Application
        • 5.2.1.3. -Rehabilitation
        • 5.2.1.4. -Training & Continuing Medical Education
        • 5.2.1.5. Virtual Reality
        • 5.2.1.6. -Simulation
        • 5.2.1.7. -Diagnostics
        • 5.2.1.8. -Virtual Reality Exposure Therapy (VRET)
        • 5.2.1.9. -Rehabilitation
        • 5.2.1.10. -Pain Distraction
      • 5.2.2. Global AR and VR in Healthcare by: Application (Value)
        • 5.2.2.1. Hospitals, Clinics, and Surgical Centers
        • 5.2.2.2. Research Organizations and Pharma Companies
        • 5.2.2.3. Research and Diagnostics Laboratories
        • 5.2.2.4. Government and Defense Institutions
        • 5.2.2.5. Others
      • 5.2.3. Global AR and VR in Healthcare Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. AR and VR in Healthcare: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Google (US)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Microsoft (US)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. DAQRI (US)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Psious (Spain)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mindmaze (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Firsthand Technology (US)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medical Realities (UK)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Atheer (US)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Augmedix (US)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Oculus VR (US)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. CAE Healthcare (US)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Philips Healthcare (Netherlands & US)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. 3D Systems (US)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. VirtaMed (Switzerland)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. HTC (Taiwan)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Siemens Healthineers (Germany)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Virtually Better (US).
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
  • 7. Global AR and VR in Healthcare Sale, by Type, Application and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global AR and VR in Healthcare (Value)
      • 7.2.1. Global AR and VR in Healthcare by: Type (Value)
        • 7.2.1.1. Augmented Reality
        • 7.2.1.2. -Surgical Application
        • 7.2.1.3. -Rehabilitation
        • 7.2.1.4. -Training & Continuing Medical Education
        • 7.2.1.5. Virtual Reality
        • 7.2.1.6. -Simulation
        • 7.2.1.7. -Diagnostics
        • 7.2.1.8. -Virtual Reality Exposure Therapy (VRET)
        • 7.2.1.9. -Rehabilitation
        • 7.2.1.10. -Pain Distraction
      • 7.2.2. Global AR and VR in Healthcare by: Application (Value)
        • 7.2.2.1. Hospitals, Clinics, and Surgical Centers
        • 7.2.2.2. Research Organizations and Pharma Companies
        • 7.2.2.3. Research and Diagnostics Laboratories
        • 7.2.2.4. Government and Defense Institutions
        • 7.2.2.5. Others
      • 7.2.3. Global AR and VR in Healthcare Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. AR and VR in Healthcare: by Type(USD Million)
  • Table 2. AR and VR in Healthcare Augmented Reality , by Region USD Million (2019-2024)
  • Table 3. AR and VR in Healthcare -Surgical Application , by Region USD Million (2019-2024)
  • Table 4. AR and VR in Healthcare -Rehabilitation , by Region USD Million (2019-2024)
  • Table 5. AR and VR in Healthcare -Training & Continuing Medical Education , by Region USD Million (2019-2024)
  • Table 6. AR and VR in Healthcare Virtual Reality , by Region USD Million (2019-2024)
  • Table 7. AR and VR in Healthcare -Simulation , by Region USD Million (2019-2024)
  • Table 8. AR and VR in Healthcare -Diagnostics , by Region USD Million (2019-2024)
  • Table 9. AR and VR in Healthcare -Virtual Reality Exposure Therapy (VRET) , by Region USD Million (2019-2024)
  • Table 10. AR and VR in Healthcare -Rehabilitation , by Region USD Million (2019-2024)
  • Table 11. AR and VR in Healthcare -Pain Distraction , by Region USD Million (2019-2024)
  • Table 12. AR and VR in Healthcare: by Application(USD Million)
  • Table 13. AR and VR in Healthcare Hospitals, Clinics, and Surgical Centers , by Region USD Million (2019-2024)
  • Table 14. AR and VR in Healthcare Research Organizations and Pharma Companies , by Region USD Million (2019-2024)
  • Table 15. AR and VR in Healthcare Research and Diagnostics Laboratories , by Region USD Million (2019-2024)
  • Table 16. AR and VR in Healthcare Government and Defense Institutions , by Region USD Million (2019-2024)
  • Table 17. AR and VR in Healthcare Others , by Region USD Million (2019-2024)
  • Table 18. South America AR and VR in Healthcare, by Country USD Million (2019-2024)
  • Table 19. South America AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 20. South America AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 21. Brazil AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 22. Brazil AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 23. Argentina AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 24. Argentina AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 25. Rest of South America AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 26. Rest of South America AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 27. Asia Pacific AR and VR in Healthcare, by Country USD Million (2019-2024)
  • Table 28. Asia Pacific AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 29. Asia Pacific AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 30. China AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 31. China AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 32. Japan AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 33. Japan AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 34. India AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 35. India AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 36. South Korea AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 37. South Korea AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 38. Taiwan AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 39. Taiwan AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 40. Australia AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 41. Australia AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 42. Rest of Asia-Pacific AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 43. Rest of Asia-Pacific AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 44. Europe AR and VR in Healthcare, by Country USD Million (2019-2024)
  • Table 45. Europe AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 46. Europe AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 47. Germany AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 48. Germany AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 49. France AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 50. France AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 51. Italy AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 52. Italy AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 53. United Kingdom AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 54. United Kingdom AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 55. Netherlands AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 56. Netherlands AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 57. Rest of Europe AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 58. Rest of Europe AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 59. MEA AR and VR in Healthcare, by Country USD Million (2019-2024)
  • Table 60. MEA AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 61. MEA AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 62. Middle East AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 63. Middle East AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 64. Africa AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 65. Africa AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 66. North America AR and VR in Healthcare, by Country USD Million (2019-2024)
  • Table 67. North America AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 68. North America AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 69. United States AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 70. United States AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 71. Canada AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 72. Canada AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 73. Mexico AR and VR in Healthcare, by Type USD Million (2019-2024)
  • Table 74. Mexico AR and VR in Healthcare, by Application USD Million (2019-2024)
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Company Basic Information, Sales Area and Its Competitors
  • Table 86. Company Basic Information, Sales Area and Its Competitors
  • Table 87. Company Basic Information, Sales Area and Its Competitors
  • Table 88. Company Basic Information, Sales Area and Its Competitors
  • Table 89. Company Basic Information, Sales Area and Its Competitors
  • Table 90. Company Basic Information, Sales Area and Its Competitors
  • Table 91. Company Basic Information, Sales Area and Its Competitors
  • Table 92. AR and VR in Healthcare: by Type(USD Million)
  • Table 93. AR and VR in Healthcare Augmented Reality , by Region USD Million (2027-2032)
  • Table 94. AR and VR in Healthcare -Surgical Application , by Region USD Million (2027-2032)
  • Table 95. AR and VR in Healthcare -Rehabilitation , by Region USD Million (2027-2032)
  • Table 96. AR and VR in Healthcare -Training & Continuing Medical Education , by Region USD Million (2027-2032)
  • Table 97. AR and VR in Healthcare Virtual Reality , by Region USD Million (2027-2032)
  • Table 98. AR and VR in Healthcare -Simulation , by Region USD Million (2027-2032)
  • Table 99. AR and VR in Healthcare -Diagnostics , by Region USD Million (2027-2032)
  • Table 100. AR and VR in Healthcare -Virtual Reality Exposure Therapy (VRET) , by Region USD Million (2027-2032)
  • Table 101. AR and VR in Healthcare -Rehabilitation , by Region USD Million (2027-2032)
  • Table 102. AR and VR in Healthcare -Pain Distraction , by Region USD Million (2027-2032)
  • Table 103. AR and VR in Healthcare: by Application(USD Million)
  • Table 104. AR and VR in Healthcare Hospitals, Clinics, and Surgical Centers , by Region USD Million (2027-2032)
  • Table 105. AR and VR in Healthcare Research Organizations and Pharma Companies , by Region USD Million (2027-2032)
  • Table 106. AR and VR in Healthcare Research and Diagnostics Laboratories , by Region USD Million (2027-2032)
  • Table 107. AR and VR in Healthcare Government and Defense Institutions , by Region USD Million (2027-2032)
  • Table 108. AR and VR in Healthcare Others , by Region USD Million (2027-2032)
  • Table 109. South America AR and VR in Healthcare, by Country USD Million (2027-2032)
  • Table 110. South America AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 111. South America AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 112. Brazil AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 113. Brazil AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 114. Argentina AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 115. Argentina AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 116. Rest of South America AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 117. Rest of South America AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 118. Asia Pacific AR and VR in Healthcare, by Country USD Million (2027-2032)
  • Table 119. Asia Pacific AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 120. Asia Pacific AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 121. China AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 122. China AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 123. Japan AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 124. Japan AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 125. India AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 126. India AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 127. South Korea AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 128. South Korea AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 129. Taiwan AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 130. Taiwan AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 131. Australia AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 132. Australia AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 133. Rest of Asia-Pacific AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 134. Rest of Asia-Pacific AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 135. Europe AR and VR in Healthcare, by Country USD Million (2027-2032)
  • Table 136. Europe AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 137. Europe AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 138. Germany AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 139. Germany AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 140. France AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 141. France AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 142. Italy AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 143. Italy AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 144. United Kingdom AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 145. United Kingdom AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 146. Netherlands AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 147. Netherlands AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 148. Rest of Europe AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 149. Rest of Europe AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 150. MEA AR and VR in Healthcare, by Country USD Million (2027-2032)
  • Table 151. MEA AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 152. MEA AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 153. Middle East AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 154. Middle East AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 155. Africa AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 156. Africa AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 157. North America AR and VR in Healthcare, by Country USD Million (2027-2032)
  • Table 158. North America AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 159. North America AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 160. United States AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 161. United States AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 162. Canada AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 163. Canada AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 164. Mexico AR and VR in Healthcare, by Type USD Million (2027-2032)
  • Table 165. Mexico AR and VR in Healthcare, by Application USD Million (2027-2032)
  • Table 166. Research Programs/Design for This Report
  • Table 167. Key Data Information from Secondary Sources
  • Table 168. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global AR and VR in Healthcare: by Type USD Million (2019-2024)
  • Figure 5. Global AR and VR in Healthcare: by Application USD Million (2019-2024)
  • Figure 6. South America AR and VR in Healthcare Share (%), by Country
  • Figure 7. Asia Pacific AR and VR in Healthcare Share (%), by Country
  • Figure 8. Europe AR and VR in Healthcare Share (%), by Country
  • Figure 9. MEA AR and VR in Healthcare Share (%), by Country
  • Figure 10. North America AR and VR in Healthcare Share (%), by Country
  • Figure 11. Global AR and VR in Healthcare share by Players 2024 (%)
  • Figure 12. Global AR and VR in Healthcare share by Players (Top 3) 2024(%)
  • Figure 13. Global AR and VR in Healthcare share by Players (Top 5) 2024(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Google (US) Revenue, Net Income and Gross profit
  • Figure 16. Google (US) Revenue: by Geography 2024
  • Figure 17. Microsoft (US) Revenue, Net Income and Gross profit
  • Figure 18. Microsoft (US) Revenue: by Geography 2024
  • Figure 19. DAQRI (US) Revenue, Net Income and Gross profit
  • Figure 20. DAQRI (US) Revenue: by Geography 2024
  • Figure 21. Psious (Spain) Revenue, Net Income and Gross profit
  • Figure 22. Psious (Spain) Revenue: by Geography 2024
  • Figure 23. Mindmaze (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Mindmaze (Switzerland) Revenue: by Geography 2024
  • Figure 25. Firsthand Technology (US) Revenue, Net Income and Gross profit
  • Figure 26. Firsthand Technology (US) Revenue: by Geography 2024
  • Figure 27. Medical Realities (UK) Revenue, Net Income and Gross profit
  • Figure 28. Medical Realities (UK) Revenue: by Geography 2024
  • Figure 29. Atheer (US) Revenue, Net Income and Gross profit
  • Figure 30. Atheer (US) Revenue: by Geography 2024
  • Figure 31. Augmedix (US) Revenue, Net Income and Gross profit
  • Figure 32. Augmedix (US) Revenue: by Geography 2024
  • Figure 33. Oculus VR (US) Revenue, Net Income and Gross profit
  • Figure 34. Oculus VR (US) Revenue: by Geography 2024
  • Figure 35. CAE Healthcare (US) Revenue, Net Income and Gross profit
  • Figure 36. CAE Healthcare (US) Revenue: by Geography 2024
  • Figure 37. Philips Healthcare (Netherlands & US) Revenue, Net Income and Gross profit
  • Figure 38. Philips Healthcare (Netherlands & US) Revenue: by Geography 2024
  • Figure 39. 3D Systems (US) Revenue, Net Income and Gross profit
  • Figure 40. 3D Systems (US) Revenue: by Geography 2024
  • Figure 41. VirtaMed (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. VirtaMed (Switzerland) Revenue: by Geography 2024
  • Figure 43. HTC (Taiwan) Revenue, Net Income and Gross profit
  • Figure 44. HTC (Taiwan) Revenue: by Geography 2024
  • Figure 45. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 46. Siemens Healthineers (Germany) Revenue: by Geography 2024
  • Figure 47. Virtually Better (US). Revenue, Net Income and Gross profit
  • Figure 48. Virtually Better (US). Revenue: by Geography 2024
  • Figure 49. Global AR and VR in Healthcare: by Type USD Million (2027-2032)
  • Figure 50. Global AR and VR in Healthcare: by Application USD Million (2027-2032)
  • Figure 51. South America AR and VR in Healthcare Share (%), by Country
  • Figure 52. Asia Pacific AR and VR in Healthcare Share (%), by Country
  • Figure 53. Europe AR and VR in Healthcare Share (%), by Country
  • Figure 54. MEA AR and VR in Healthcare Share (%), by Country
  • Figure 55. North America AR and VR in Healthcare Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Google (US)
  • Microsoft (US)
  • DAQRI (US)
  • Psious (Spain)
  • Mindmaze (Switzerland)
  • Firsthand Technology (US)
  • Medical Realities (UK)
  • Atheer (US)
  • Augmedix (US)
  • Oculus VR (US)
  • CAE Healthcare (US)
  • Philips Healthcare (Netherlands & US)
  • 3D Systems (US)
  • VirtaMed (Switzerland)
  • HTC (Taiwan)
  • Siemens Healthineers (Germany)
  • Virtually Better (US).
Select User Access Type

Key Highlights of Report


Feb 2025 226 Pages 94 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global AR and VR in Healthcare market are Google (US), Microsoft (US), DAQRI (US), Psious (Spain), Mindmaze (Switzerland), Firsthand Technology (US), Medical Realities (UK), Atheer (US), Augmedix (US), Oculus VR (US), CAE Healthcare (US), Philips Healthcare (Netherlands & US), 3D Systems (US), VirtaMed (Switzerland), HTC (Taiwan), Siemens Healthineers (Germany) and Virtually Better (US)., to name a few.
"Increased Investment in the Healthcare AR and VR" is seen as one of major influencing trends for AR and VR in Healthcare Market during projected period 2024-2032.
Augmented Reality segment in Global market to hold robust market share owing to "Increasing Penetration of Connected Devices in the Healthcare Sector ".

Know More About Global AR and VR in Healthcare Market Report?